Array BioPharma (ARRY) Reports Encouraging Data from MEK162 in Ongoing Phase 2
Go back to Array BioPharma (ARRY) Reports Encouraging Data from MEK162 in Ongoing Phase 2| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 4.92 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.92 | 52 Week High | $7.27 | |||
| Open | $4.92 | 52 Week Low | $2.39 | |||
| Day High | $4.92 | P/E | N/A | |||
| Day Low | $4.92 | EPS | $-0.61 | |||
| Volume | 7,486 | |||||

